Home/Filings/4/0001477286-10-000004
4//SEC Filing

Mayer Christine 4

Accession 0001477286-10-000004

CIK 0000885590other

Filed

Aug 9, 8:00 PM ET

Accepted

Aug 10, 12:08 PM ET

Size

16.0 KB

Accession

0001477286-10-000004

Insider Transaction Report

Form 4
Period: 2010-08-09
Mayer Christine
SVP,BTA Pharmaceuticals, Inc.
Transactions
  • Sale

    Common Stock, no par value

    2010-08-09$22.95/sh2,000$45,9002,000 total
  • Exercise/Conversion

    Stock Options (right to purchase)

    2010-08-0920,000255,333 total
    Exercise: $17.45From: 2009-08-03Exp: 2010-08-09Common Stock, no par value (20,000 underlying)
  • Sale

    Common Stock, no par value

    2010-08-09$22.90/sh2,000$45,80018,000 total
  • Sale

    Common Stock, no par value

    2010-08-09$22.93/sh2,000$45,8604,000 total
  • Sale

    Common Stock, no par value

    2010-08-09$22.96/sh2,000$45,9200 total
  • Exercise/Conversion

    Common Stock, no par value

    2010-08-09$17.45/sh+20,000$349,00020,000 total
  • Sale

    Common Stock, no par value

    2010-08-09$22.91/sh8,000$183,28010,000 total
  • Sale

    Common Stock, no par value

    2010-08-09$22.92/sh4,000$91,6806,000 total

Issuer

BIOVAIL Corp

CIK 0000885590

Entity typeother

Related Parties

1
  • filerCIK 0001477286

Filing Metadata

Form type
4
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 12:08 PM ET
Size
16.0 KB